Newly Funded Research Grants 2025

Dr. Abhirami Iyer, Washington University School of Medicine

Defining the Role of Microglial Tau in 4R tauopathies

Dr. Seiji Kaji, Kyoto University

Elucidation of Apoe-induced glial cell Tau pathology in PSP

Dr. Yuhao (Harry) Min, Mayo Clinic Jacksonville

Investigating Ddr2 gene downregulation as a novel therapeutic target for PSP and related tauopathies

Dr. Jennifer Rauch, University of Massachusetts Amherst

Development of Novel Models to Understand Tau Seeding in PSP and CBD

Newly Funded Research Grants 2024

Dr. Jessica Rexach, UCLA

Defining the unique immunogenetic landscape of PSP compared to related dementias

Dr. Yang You, Mayo Clinic Jacksonville

Characterization of plasma-derived extracellular vesicle proteomics for biomarker development of PSP and CBD

Dr. Peng Zhong, University of Nebraska Medical Center

Mechanisms of Sleep Disturbances in a Mouse Model of Tauopathy

Dr. Steven Boeynaems, Baylor College of Medicine

Dissecting the role of endosomal Toll-like receptors in PSP and CBD

Dr. Kathryn Bowles, University of Edinburgh

Investigating mitochondrial dysfunction as an early pathogenic mechanism of primary tauopathies, using MAPT splicing mutation iPSC-organoids

Dr. Maura Malpetti, University of Cambridge

Blood-based fingerprints of neuroinflammation in people with PSP and CBD

Newly Funded Research Grants 2023

Dr. Blas Couto, Institute of Translational and Cognitive Neuroscience (INCyT), Buenos Aires, Argentina

Epidemiology and Tau Biology in a Longitudinal Cohort of Argentinian Patients with PSP and CBD

Dr. Kurt Farrell, Icahan School of Medicine at Mount Sinai, New York, NY

Understanding the Roles of Risk Loci Implicated in Genome-Wide Association Studies of PSP

Dr. Luana Fioriti, Mario Negri Institute for Pharmacological Research, Milan, Italy

Potential Therapeutic Biomarkers for Progressive Supranuclear Palsy

Dr. Joseph B. Rayman, Columbia University Irving Medical Center, New York, NY

Development of Small Molecule Inhibitors of Tau Oligomerization

Ongoing Funded Grants

Dr. Maria Catarina Lima da Silva, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Investigation of ULK1-Based Autophagy Activators as Therapeutics for Tauopathies

Dr. Franziska Hopfner, Department of Neurology, Hannover Medical School, Hannover, Germany

MicroRNA profile of isolated brain cell populations in PSP